含外膜蛋白、III型分泌系统蛋白和包涵体膜蛋白的多阶段疫苗可预防沙眼衣原体生殖道感染及病理损伤
该研究在小鼠阴道攻击模型中比较了单抗原、双抗原与多阶段疫苗对沙眼衣原体(Chlamydia muridarum)感染的保护效果。含外膜蛋白(MOMP、PmpG)、III型分泌系统蛋白(CdsF、TC0873)和包涵体膜蛋白(IncA、TC0500)的多阶段疫苗对阴道排菌和上生殖道病理的保护显著优于仅针对胞外期或胞内期的疫苗。不同佐剂(ISCOMATRIX、VIDO、CTA1-DD、ADVAX)和免疫途径(皮下、鼻内)可进一步增强对感染的保护。
要点
- 单抗原或双抗原疫苗主要针对胞外期,可诱导显著但相近的阴道排菌保护。
- 多阶段疫苗对阴道排菌和上生殖道病理的保护显著优于仅针对胞外期或胞内期的疫苗。
- 不同佐剂与皮下或鼻内免疫途径可进一步增强对感染的保护。
核心结论
- 针对胞外沙眼衣原体抗原的疫苗所诱导的保护,可通过纳入胞内期表达的沙眼衣原体抗原而得到改善。
研究设计与样本
- 在小鼠阴道攻击模型中比较单抗原疫苗、双抗原疫苗与多阶段疫苗对沙眼衣原体(Chlamydia muridarum)感染的保护效果。
- 多阶段疫苗含外膜蛋白(MOMP、PmpG)、III型分泌系统蛋白(CdsF、TC0873)和包涵体膜蛋白(IncA、TC0500)。
- 比较的佐剂包括ISCOMATRIX(IMX)、PCEP/polyI:C/IDR1002(VIDO)、CTA1-DD和ADVAX。
- 免疫途径包括皮下(SQ)和鼻内(IN)。
主要发现
- 单抗原疫苗(如MOMP)和双抗原疫苗(如MOMP与PmpG)主要针对胞外期,与未免疫对照小鼠相比诱导显著但相近的阴道排菌保护。
- 使用不同佐剂和多种免疫途径进一步增强了对感染的保护。
- 多阶段疫苗对阴道排菌和上生殖道病理的保护显著优于仅针对胞外期或胞内期的疫苗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pathogens with a complex lifecycles can effectively evade host immunity in part due to each developmental stage expressing unique sets of antigens. Multisubunit vaccines incorporating signature antigens reflecting distinct developmental stages (multistage vaccines) have proven effective against viral, bacterial and parasitic infection at preventing pathogen evasion of host immunity. Chlamydia trachomatis is characterized by a biphasic extra/intracellular developmental cycle and an acute/persistent (latent) metabolic state; hence a multistage vaccine may prevent immune evasion and enhance clearance. Here we tested the efficacy of a multistage vaccine containing outer membrane (MOMP and PmpG), type three secretion system (T3SS) (CdsF and TC0873) and inclusion membrane proteins (IncA and TC0500) in mice against an intravaginal challenge with Chlamydia muridarum. Comparison of single (eg. MOMP) and double antigen vaccines (eg. MOMP and PmpG), largely targeting the extracellular stage, elicited significant yet comparable protection against vaginal shedding when compared to unimmunized control mice. Utilization of different adjuvants (ISCOMATRIX - IMX, PCEP/polyI:C/IDR1002 - VIDO, CTA1-DD and ADVAX) and numerous immunization routes (subcutaneous - SQ and intranasal - IN) further enhanced protection against infection. However, a multistage vaccine elicited significantly greater protection against vaginal shedding and upper genital tract pathology than vaccines targeting only extra- or intracellular stages. This indicates that protection elicited by a vaccine targeting extracellular chlamydial antigens could be improved by including chlamydial antigen expressed during intracellular phase.
引用
- O'Meara CP, Armitage CW, Andrew DW, et al. Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology. Vaccine. 2017. PMID: 28602608. doi:10.1016/j.vaccine.2017.05.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。